Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug and giving them in different ways
after surgery may kill more tumor cells. It is not yet known which chemotherapy regimen is
more effective in treating older women with breast cancer.
PURPOSE: This randomized phase III trial is studying different combination chemotherapy
regimens to see how well they work in treating older women who have undergone surgery for
breast cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Alliance for Clinical Trials in Oncology
Collaborators:
National Cancer Institute (NCI) NCIC Clinical Trials Group